During this virtual panel, industry experts will discuss practical examples and considerations for transforming manufacturing processes.

Innovation in pharmaceutical manufacturing is accelerating, driven by the need for greater efficiency, flexibility and product quality. As new technologies and materials are introduced, packaging systems and product-contact materials are playing an increasingly critical role in ensuring product safety and performance.
From single-use technologies to complex polymer-based container closure systems, manufacturers must carefully evaluate how materials interact with drug products. Extractables and leachables (E&L) have become a key consideration, with the potential to impact product stability, efficacy and regulatory compliance if not properly managed.
In this virtual panel, industry experts will share practical steps for advancing pharmaceutical manufacturing while embedding robust packaging strategies and E&L risk assessments into development and production. Attendees will gain insight into how a proactive, integrated approach can minimise risk, streamline approvals and support successful product lifecycle management.
Join this virtual panel to explore how to:
- Drive manufacturing innovation while maintaining control over product–packaging interactions
- Integrate extractables and leachables (E&L) assessments early in development
- Select and qualify packaging materials and container closure systems with confidence
- Address challenges associated with single-use systems and polymer components
- Align innovation strategies with regulatory expectations for E&L and packaging
Key learning points:
- Understand the growing importance of packaging in pharmaceutical manufacturing innovation
- Identify common sources of extractables and leachables across manufacturing and packaging systems
- Learn practical approaches to E&L study design and risk-based evaluation
- Explore how analytical testing supports material qualification and ongoing monitoring
- Discover strategies to ensure product quality, safety and compliance throughout the lifecycle
This panel is designed for professionals working at the sharp end of pharmaceutical manufacturing, including heads of operations and manufacturing, process development and engineering leads, quality and regulatory affairs directors, and senior professionals responsible for digital transformation.
Be an early registrant, secure your spot now >>
A panel of industry experts will be confirmed soon, register now to be the first to know who will be leading the discussion.
Is the panel discussion free?
Yes – there is no charge to watch the panel discussion, either live or on-demand.
When will the panel discussion take place?
21 May 2026 at 3PM GMT.
Can I watch it later?
The panel discussion will become available to watch on-demand shortly after the live webinar takes place.
What are the benefits of attending live?
You’ll be able to ask the speakers your questions, which will be answered live in the Q&A towards the end of the session.
How long will the panel discussion be?
This panel discussion will last up to an hour.
What do I need to watch this panel discussion?
All you need is a computer with an internet connection. We recommend using headphones if possible if you’re in an office environment.
Practical steps for innovating pharmaceutical manufacturing
Topics
- AI, analytics and decision support
- Analytical and bioanalysis
- Automation and robotics
- Bioprocessing and biomanufacturing
- Chromatography and separations
- Data integrity
- Environmental Monitoring
- Excipients and raw materials
- GMP and quality management systems (QMS)
- Quality, microbiology and contamination control
- Sterility and rapid methods
- Upstream processing
- US Pharmacopeia (USP)







